Alkermes Plc's schizophrenia drug met its main goal of keeping in check a common side effect of antipsychotic medicines - weight gain - taking the company one step closer to a marketing approval for the treatment.
Alkermes schizophrenia drug keeps weight gain side effect in check
![Alkermes schizophrenia drug keeps weight gain side effect in check]()
Reviewed by jenisht
on
November 30, 2018
Rating:
No comments: